Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$3.52B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.87B |
| 5 |
Eli Lilly
LLY
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.8B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.78B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$703M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.3% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Methanex
MEOH
$4.2B
| $10.1M | ﹤0.01% |
266,326
-230,153
| -46% | -$8.44M |
|
3077
Kemper
KMPR
$1.72B
| $10.1M | ﹤0.01% |
204,902
+41,547
| +25% | +$2.09M |
|
3078
Usana Health Sciences
USNA
$422M
| $10.1M | ﹤0.01% |
189,252
+47,482
| +33% | +$2.57M |
|
3079
Abercrombie & Fitch
ANF
$4.84B
| $10.1M | ﹤0.01% |
439,304
-404,710
| -48% | -$7.97M |
|
3080
Nuveen ESG Large-Cap Growth ETF
NULG
$2.77B
| $10M | ﹤0.01% |
205,511
+43,850
| +27% | +$2.16M |
|
3081
Bausch Health
BHC
$2.41B
| $10M | ﹤0.01% |
1,596,167
+498,042
| +45% | +$3.48M |
|
3082
Nuveen Core Plus Impact Fund
NPCT
$281M
| $10M | ﹤0.01% |
967,168
+222,979
| +30% | +$2.34M |
|
3083
ARK Blockchain & Fintech Innovation ETF
ARKF
$752M
| $9.99M | ﹤0.01% |
700,336
-33,382
| -5% | -$517K |
|
|
DCPH
3084
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $9.99M | ﹤0.01% |
609,258
+7,555
| +1% | +$123K |
|
3085
iShares MSCI Chile ETF
ECH
$1.04B
| $9.98M | ﹤0.01% |
368,411
-156,156
| -30% | -$4.01M |
|
|
MVF
3086
DELISTED
BlackRock MuniVest Fund
MVF
| $9.96M | ﹤0.01% |
1,421,196
+301,294
| +27% | +$2.02M |
|
3087
Sensient Technologies
SXT
$5.41B
| $9.93M | ﹤0.01% |
136,208
-112,316
| -45% | -$8.05M |
|
|
SHOE
3088
Shoe Station Group
SHOE
$419M
| $9.93M | ﹤0.01% |
415,169
+74,840
| +22% | +$1.79M |
|
3089
PMV Pharmaceuticals
PMVP
$62.4M
| $9.91M | ﹤0.01% |
1,139,262
-174,641
| -13% | -$1.86M |
|
|
FPI
3090
Farmland Partners
FPI
$418M
| $9.91M | ﹤0.01% |
795,311
+269,316
| +51% | +$3.56M |
|
3091
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $9.9M | ﹤0.01% |
530,466
-110,130
| -17% | -$1.99M |
|
3092
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$334M
| $9.9M | ﹤0.01% |
125,668
-17,560
| -12% | -$1.39M |
|
3093
Kaiser Aluminum
KALU
$2.68B
| $9.9M | ﹤0.01% |
130,352
-7,927
| -6% | -$635K |
|
|
LGF.B
3094
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $9.9M | ﹤0.01% |
1,822,789
+255,810
| +16% | +$1.7M |
|
3095
John Hancock Multifactor Small Cap ETF
JHSC
$748M
| $9.87M | ﹤0.01% |
322,738
-14,841
| -4% | -$458K |
|
3096
Payoneer
PAYO
$2.4B
| $9.87M | ﹤0.01% |
1,803,666
+649,855
| +56% | +$4.08M |
|
3097
RPC Inc
RES
$1.28B
| $9.85M | ﹤0.01% |
1,108,210
+58,413
| +6% | +$527K |
|
3098
International Bancshares
IBOC
$4.74B
| $9.84M | ﹤0.01% |
215,088
-18,879
| -8% | -$909K |
|
|
PLL
3099
DELISTED
Piedmont Lithium
PLL
| $9.83M | ﹤0.01% |
223,360
-220,166
| -50% | -$12.2M |
|
3100
State Street SPDR S&P Capital Markets ETF
KCE
$472M
| $9.83M | ﹤0.01% |
124,670
-11,766
| -9% | -$936K |
|
Similar funds
Morgan Stanley's Q4 2022 Portfolio in Review
As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 200 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.
- Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
- Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
- Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
- Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
- Morgan Stanley opened 200 new positions and closed 311 in Q4 2022.
- Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.